Skip to main content

Market Overview

36 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • Taronis Technologies, Inc. (NASDAQ: TRNX) shares gained 54.1% to $0.322 after the company generated record MagneGas production.
  • Oasmia Pharmaceutical AB (NASDAQ: OASM) shares climbed 27.4% to $2.56. Oasmia Pharmaceutical shares surged over 63% Friday after the company announced that an agreement has been reached with its largest shareholder Arwidsro to solve its outstanding balances. Arwidsro increased its investment in Oasmia.
  • Soliton, Inc. (NASDAQ: SOLY) shares climbed 19.3% to $13.64. Soliton will announce cellulite trial data for 26-week period on July 15, 2019.
  • Sol Gel Technologies Ltd (NASDAQ: SLGL) gained 15.1% to $10.30 after announcing positive results from its Phase 3 program evaluating Epsolay microencapsulated benzoyl peroxide cream, 5%, made with the company’s proprietary microencapsulation technology, for the treatment of papulopustular rosacea.
  • Sangamo Therapeutics, Inc. (NASDAQ: SGMO) rose 14.1% to $13.01 after the company presented data from its Phase 1/2 Alta study evaluating investigational SB-525 gene therapy in patients with severe hemophilia A over the weekend.
  • Orion Group Holdings, Inc. (NYSE: ORN) rose 13.3% to $3.5100. B. Riley upgraded Orion Group from Neutral to Buy and raised the price target from $4 to $5.
  • SemiLEDs Corporation (NASDAQ: LEDS) rose 12.2% to $3.5000.
  • Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) rose 11.9% to $0.7275 after the company announced it has completed the safety evaluation period for the 200 mg cohort of the Phase 1b/2 trial of vecabrutinib; to date, the safety profile has had no drug-related adverse events.
  • Prevail Therapeutics Inc. (NASDAQ: PRVL) gained 11.7% to $11.74 after the company received FDA fast track designation for PR001 for the treatment of Parkinson's disease patients with a GBA1 mutation.
  • Aytu BioScience, Inc. (NASDAQ: AYTU) rose 10.3% to $2.04 after the company reported publication of clinical study results demonstrating effectiveness of Natesto regardless of patients' baseline Hypogonadism severity.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) gained 10.3% to $13.52.
  • Tyme Technologies Inc (NASDAQ: TYME) gained 9.7% to $1.5899. Tyme Technologies shares climbed around 19% Friday after the company presented updated data for its Phase 2 Study of TYME-88-Pancreatic Cancer at the ESMO GI 2019.
  • Unum Therapeutics Inc. (NASDAQ: UMRX) shares rose 9.6% to $2.63 after gaining 7.62% on Friday.
  • J.Jill, Inc. (NYSE: JILL) rose 8.6% to $2.28.
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) gained 7.7% to $7.17.
  • AZZ Inc. (NYSE: AZZ) jumped 6.6% to $49.12 after reporting better-than-expected results for its first quarter.
  • Weight Watchers International, Inc. (NASDAQ: WW) jumped 6% to $20.92.
  • Symantec Corporation (NASDAQ: SYMC) rose 3.7% to $25.93 after Bloomberg reported Sunday that Broadcom has secured financing for acquisition.

 

Check out these big penny stock gainers and losers

Losers

  • Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) fell 22.7% to $10.40 after the company released mixed study results from two Phase 3 clinical trials evaluating lumateperone as monotherapy in the treatment of major depressive episodes associated with bipolar depression.
  • Nano Dimension Ltd. (NASDAQ: NNDM) shares dipped 19.6% to $0.4179 after the company reported preliminary Q2 sales of $1 million to $1.2 million, which is below management's expectations.
  • Camber Energy, Inc. (NYSE: CEI) dropped 18.7% to $2.39 after the company announced it received a deficiency letter from NYSE American stating that the company is not in compliance with continued listing standards.
  • CannTrust Holdings Inc. (NYSE: CTST) shares tumbled 17.8% to $4.0587 after Health Canada notified the company that its greenhouse facility in Ontario is not compliance with certain regulations and placed a hold on inventory from this until the company is in compliance.
  • Noah Holdings Limited (NYSE: NOAH) fell 17.6% to $36.85.
  • Coherus BioSciences, Inc. (NASDAQ: CHRS) shares dropped 15.7% to $ 19.16. Coherus BioSciences announced that UDENYCA preliminary unaudited net sales for the second quarter expected in the range of $79 million-$84 million.
  • Jaguar Health, Inc. (NASDAQ: JAGX) shares dipped 11.2% to $3.7201.
  • Puyi Inc. (NASDAQ: PUYI) tumbled 10.2% to $7.74.
  • Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares dipped 9.2% to $6.51.
  • Neurotrope, Inc. (NASDAQ: NTRP) dropped 9.1% to $6.80.
  • MicroStrategy Incorporated (NASDAQ: MSTR) shares dipped 7.8% to $129.32.
  • Catalyst Biosciences, Inc. (NASDAQ: CBIO) fell 7.7% to $8.59 after meeting the primary endpoint of reduction in annualized bleeding rate in the Phase 2 trial of subcutaneous marzeptacog alfa (activated) in patients with hemophilia A or B with inhibitors.
  • Advanced Energy Industries, Inc. (NASDAQ: AEIS) dipped 7% to $51.46 after DA Davidson downgraded the company's stock from Buy to Neutral.
  • Ichor Holdings, Ltd. (NASDAQ: ICHR) dropped 6.8% to $22.73 after DA Davidson downgraded the stock from Buy to Neutral and lowered the price target from $32 to $25.
  • Deutsche Bank AG (NYSE: DB) fell 5.5% to $7.59 after the company announced it will exit its global equities and trading businesses and reduce workforce by around 18,000 employees.
  • LG Display Co., Ltd. (NYSE: LPL) shares fell 5.2% to $7.07 after Rosenblatt downgraded Apple's stock due to iPhone sales concerns. LG Display is an iPhone supplier. The company may also be facing pressure from Japan-Korea trade issues.
  • NetApp, Inc. (NASDAQ: NTAP) fell 3.8% to $60.06 after Citigroup downgraded the company's stock from Neutral to Sell and lowered the price target from $67 to $55.
  • Apple Inc. (NASDAQ: AAPL) fell 2.5% to $199.21 after Rosenblatt downgraded the company's stock from Neutral to Sell due to iPhone sale concerns.
 

Related Articles (AAPL + AEIS)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com